IMAX Research Development from 2010 to 2026

IMA Stock  EUR 30.20  0.60  2.03%   
IMAX's Research Development is decreasing over the last several years with slightly volatile swings. Research Development is estimated to finish at about 8.9 M this year. During the period from 2010 to 2026 IMAX Corporation Research Development regressed destribution of quarterly values had coefficient of variationof  45.20 and r-value of (0.73). View All Fundamentals
 
Research Development  
First Reported
2016-12-31
Previous Quarter
1.5 M
Current Value
1.5 M
Quarterly Volatility
1.4 M
 
Covid
 
Interest Hikes
Check IMAX financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IMAX's main balance sheet or income statement drivers, such as Discontinued Operations of 428.7 K, Interest Expense of 9.8 M or Selling General Administrative of 129.1 M, as well as many indicators such as . IMAX financial statements analysis is a perfect complement when working with IMAX Valuation or Volatility modules.
  
This module can also supplement various IMAX Technical models . Check out the analysis of IMAX Correlation against competitors.
The Research Development trend for IMAX Corporation offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether IMAX is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest IMAX's Research Development Growth Pattern

Below is the plot of the Research Development of IMAX Corporation over the last few years. It is IMAX's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IMAX's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

IMAX Research Development Regression Statistics

Arithmetic Mean11,207,661
Geometric Mean10,016,233
Coefficient Of Variation45.20
Mean Deviation4,463,418
Median12,730,000
Standard Deviation5,066,257
Sample Variance25.7T
Range16.3M
R-Value(0.73)
Mean Square Error12.9T
R-Squared0.53
Significance0.0009
Slope(729,178)
Total Sum of Squares410.7T

IMAX Research Development History

20268.9 M
20254.6 M
20245.1 M
202310.1 M
20225.3 M
20216.9 M
20205.6 M

About IMAX Financial Statements

IMAX stakeholders use historical fundamental indicators, such as IMAX's Research Development, to determine how well the company is positioned to perform in the future. Although IMAX investors may analyze each financial statement separately, they are all interrelated. For example, changes in IMAX's assets and liabilities are reflected in the revenues and expenses on IMAX's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IMAX Corporation. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development4.6 M8.9 M

Currently Active Assets on Macroaxis

Other Information on Investing in IMAX Stock

IMAX financial ratios help investors to determine whether IMAX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IMAX with respect to the benefits of owning IMAX security.